These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 18394720)

  • 21. Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflammation.
    Schlosburg JE; Kinsey SG; Lichtman AH
    AAPS J; 2009 Mar; 11(1):39-44. PubMed ID: 19184452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Critical enzymes involved in endocannabinoid metabolism.
    Basavarajappa BS
    Protein Pept Lett; 2007; 14(3):237-46. PubMed ID: 17346227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does the hydrolysis of 2-arachidonoylglycerol regulate its cellular uptake?
    Fowler CJ; Ghafouri N
    Pharmacol Res; 2008 Jul; 58(1):72-6. PubMed ID: 18675915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis.
    Navarria A; Tamburella A; Iannotti FA; Micale V; Camillieri G; Gozzo L; Verde R; Imperatore R; Leggio GM; Drago F; Di Marzo V
    Pharmacol Res; 2014 Sep; 87():151-9. PubMed ID: 24861565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain.
    Valenti M; Viganò D; Casico MG; Rubino T; Steardo L; Parolaro D; Di Marzo V
    Cell Mol Life Sci; 2004 Apr; 61(7-8):945-50. PubMed ID: 15095014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anandamide hydrolysis: a new target for anti-anxiety drugs?
    Gaetani S; Cuomo V; Piomelli D
    Trends Mol Med; 2003 Nov; 9(11):474-8. PubMed ID: 14604824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ex vivo imaging of fatty acid amide hydrolase activity and its inhibition in the mouse brain.
    Glaser ST; Gatley SJ; Gifford AN
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1088-97. PubMed ID: 16278311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progesterone up-regulates anandamide hydrolase in human lymphocytes: role of cytokines and implications for fertility.
    Maccarrone M; Valensise H; Bari M; Lazzarin N; Romanini C; Finazzi-Agrò A
    J Immunol; 2001 Jun; 166(12):7183-9. PubMed ID: 11390466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alteration of endocannabinoid system in human gliomas.
    Wu X; Han L; Zhang X; Li L; Jiang C; Qiu Y; Huang R; Xie B; Lin Z; Ren J; Fu J
    J Neurochem; 2012 Mar; 120(5):842-9. PubMed ID: 22176552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fatty acid amide hydrolase: biochemistry, pharmacology, and therapeutic possibilities for an enzyme hydrolyzing anandamide, 2-arachidonoylglycerol, palmitoylethanolamide, and oleamide.
    Fowler CJ; Jonsson KO; Tiger G
    Biochem Pharmacol; 2001 Sep; 62(5):517-26. PubMed ID: 11585048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of fatty-acid amide hydrolase accelerates acquisition and extinction rates in a spatial memory task.
    Varvel SA; Wise LE; Niyuhire F; Cravatt BF; Lichtman AH
    Neuropsychopharmacology; 2007 May; 32(5):1032-41. PubMed ID: 17047668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet.
    Starowicz KM; Cristino L; Matias I; Capasso R; Racioppi A; Izzo AA; Di Marzo V
    Obesity (Silver Spring); 2008 Mar; 16(3):553-65. PubMed ID: 18239598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of nitric oxide donors on membrane tritium accumulation of endocannabinoids and related endogenous lipids.
    Thors L; Fowler CJ
    Eur J Pharmacol; 2009 Oct; 621(1-3):10-8. PubMed ID: 19715690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The novel reversible fatty acid amide hydrolase inhibitor ST4070 increases endocannabinoid brain levels and counteracts neuropathic pain in different animal models.
    Caprioli A; Coccurello R; Rapino C; Di Serio S; Di Tommaso M; Vertechy M; Vacca V; Battista N; Pavone F; Maccarrone M; Borsini F
    J Pharmacol Exp Ther; 2012 Jul; 342(1):188-95. PubMed ID: 22514334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate.
    Vandevoorde S; Fowler CJ
    Br J Pharmacol; 2005 Aug; 145(7):885-93. PubMed ID: 15895107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endocannabinoids: synthesis and degradation.
    Di Marzo V
    Rev Physiol Biochem Pharmacol; 2008; 160():1-24. PubMed ID: 18481028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fatty acid amide hydrolase inhibitors--progress and potential.
    Khanna IK; Alexander CW
    CNS Neurol Disord Drug Targets; 2011 Aug; 10(5):545-58. PubMed ID: 21631410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The fatty acid amide hydrolase (FAAH).
    Deutsch DG; Ueda N; Yamamoto S
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):201-10. PubMed ID: 12052036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Piperazinyl carbamate fatty acid amide hydrolase inhibitors and transient receptor potential channel modulators as "dual-target" analgesics.
    Maione S; Costa B; Piscitelli F; Morera E; De Chiaro M; Comelli F; Boccella S; Guida F; Verde R; Ortar G; Di Marzo V
    Pharmacol Res; 2013 Oct; 76():98-105. PubMed ID: 23911581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conformational requirements for endocannabinoid interaction with the cannabinoid receptors, the anandamide transporter and fatty acid amidohydrolase.
    Reggio PH; Traore H
    Chem Phys Lipids; 2000 Nov; 108(1-2):15-35. PubMed ID: 11106780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.